NRC Health director receives $150k stock grant

Bhandari Parul reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Bhandari Parul reported acquisition or exercise transactions in this Form 4 filing.

NRC HEALTH director Parul Bhandari reported an equity grant of 7,697 shares of Common Stock as annual compensation. The award represents restricted stock units valued at $150,000, calculated using the closing price on the day before NRC HEALTH’s 2026 annual stockholder meeting.

The grant was made under the company’s 2025 Omnibus Incentive Plan at a stated price of $0.0000 per share, reflecting that this is a compensation award rather than an open-market purchase. All 7,697 shares will vest and become exercisable on the date of the company’s 2027 annual stockholder meeting, subject to standard vesting, forfeiture, and termination conditions.

Insider Trade Summary

Grant/Award: 7,697 shares

Grant/Award 1 txn

Insider Bhandari Parul

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	7,697	$0.00	$0.00

Holdings After Transaction: Common Stock — 7,697 shares (Direct)

Footnotes (1)

1. F1. This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

Key Figures

Shares granted: 7,697 shares Grant value: $150,000 Price basis: Closing price before 2026 meeting +3 more

6 metrics

Shares granted 7,697 shares Common Stock awarded as restricted stock units to director

Grant value $150,000 Annual equity compensation amount converted into restricted stock units

Price basis Closing price before 2026 meeting Used to divide $150,000 into number of units

Reported transaction price $0.0000 per share Indicates no cash paid; compensation grant

Post-transaction holdings 7,697 shares Total shares following the reported grant

Vesting timing 2027 annual meeting Restricted stock units vest on 2027 stockholder meeting date

Key Terms

restricted stock units, annual equity compensation, 2025 Omnibus Incentive Plan

3 terms

restricted stock units financial

"This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

annual equity compensation financial

"This share award represents annual equity compensation in the form of a grant of restricted stock units"

2025 Omnibus Incentive Plan financial

"under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable"

An omnibus incentive plan is a company-wide program that authorizes awards of pay tied to performance and retention—such as stock options, restricted shares, cash bonuses and other rewards—here labeled for the year it was adopted (2025). Investors care because it affects how much ownership can be issued, dilutes existing shareholders, and aligns executives’ and employees’ incentives with company goals, similar to giving team members a stake in the outcome.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did NRC (NRC) director Parul Bhandari report?

Director Parul Bhandari reported receiving 7,697 shares of NRC HEALTH Common Stock as an equity grant. The award represents restricted stock units valued at $150,000, granted as annual board compensation under the company’s 2025 Omnibus Incentive Plan and not an open-market share purchase.

How was the $150,000 NRC (NRC) stock award to Parul Bhandari calculated?

The $150,000 equity award was converted into 7,697 restricted stock units by dividing $150,000 by the closing share price on the trading day before NRC HEALTH’s 2026 annual stockholder meeting. This method ties the number of units to the company’s market price at that time.

When will Parul Bhandari’s NRC (NRC) restricted stock units vest?

The restricted stock units granted to Parul Bhandari will vest and become exercisable on the date of NRC HEALTH’s 2027 annual stockholder meeting. Vesting remains subject to the award’s vesting, forfeiture, and termination provisions described in the company’s 2025 Omnibus Incentive Plan.

Did Parul Bhandari pay cash for the 7,697 NRC (NRC) shares received?

No cash was paid for this grant; the transaction price per share is reported as $0.0000. The 7,697 shares represent equity compensation in the form of restricted stock units with a grant value of $150,000, awarded under NRC HEALTH’s 2025 Omnibus Incentive Plan.

What plan governs the NRC (NRC) equity award to director Parul Bhandari?

The equity award is granted under NRC HEALTH’s 2025 Omnibus Incentive Plan. This plan provides for annual equity compensation to directors, and the specific award to Parul Bhandari is subject to the plan’s vesting schedule, forfeiture conditions, and termination provisions through the 2027 annual meeting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/25/2026 - 04:42 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Bhandari Parul

(Last) (First) (Middle)

C/O NRC HEALTH

1245 Q STREET

(Street)

LINCOLN NEBRASKA 68508

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
NRC HEALTH [ NRC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/23/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/23/2026		A		7,697(1)	A(1)	$0	7,697	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. This share award represents annual equity compensation in the form of a grant of restricted stock units equal to $150,000, divided by the closing price on the date immediately preceding the Issuer's 2026 annual meeting of stockholders, under the Issuer's 2025 Omnibus Incentive Plan. The award will vest and become exercisable on the date of the Issuer's 2027 annual stockholder meeting, subject to vesting, forfeiture, and termination provisions.

	/s/ Parul Bhandari, by Christopher Kortum, attorney-in-fact, pursuant to a POA previously filed with the SEC	06/25/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)